To address the molecular mechanism of CFIm25 defense against HCC cell invasion and metastasis, we investigated the MAPKs and Akt signal pathways, which are two main pathways for tumor proliferation and metastasis [17–20]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.